XML 27 R12.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Financial Instruments | 9 Months Ended
--- | ---
Jan. 31, 2025
Fair Value Disclosures [Abstract] |
Financial Instruments | Financial Instruments The following tables show the Company’s financial instruments and balance sheet classification as of January 31, 2025 and April 30, 2024:
| January 31, 2025
| Fair Value Measurement |  | Balance Sheet Classification
| Cost |  | Unrealized Gains |  | Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities, Current |  | Marketable Securities, Non- current |  | Other Accrued Liabilities
| (in thousands)
Changes in Fair Value Recorded in |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other Comprehensive Income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commercial paper | $ | 4,650 |  |  | $ | — |  |  | $ | (3) |  |  | $ | 4,647 |  |  | $ | — |  |  | $ | 4,647 |  |  | $ | — |  |  | $ | — |
Corporate notes/bonds | 31,030 |  |  | 76 |  |  | (32) |  |  | 31,074 |  |  | — |  |  | 17,470 |  |  | 13,604 |  |  | — |
U.S. Treasury and Agency Securities | 4,466 |  |  | 5 |  |  | (1) |  |  | 4,470 |  |  | — |  |  | 3,971 |  |  | 499 |  |  | — |
Total debt investments | $ | 40,146 |  |  | $ | 81 |  |  | $ | (36) |  |  | $ | 40,191 |  |  | $ | — |  |  | $ | 26,088 |  |  | $ | 14,103 |  |  | $ | — |
Changes in Fair Value Recorded in |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mutual funds (1) |  |  |  |  |  |  | $ | 241,504 |  |  | $ | — |  |  | $ | 14,570 |  |  | $ | 226,934 |  |  | $ | — |
Total equity investments |  |  |  |  |  |  | $ | 241,504 |  |  | $ | — |  |  | $ | 14,570 |  |  | $ | 226,934 |  |  | $ | — |
Cash |  |  |  |  |  |  | $ | 604,876 |  |  | $ | 604,876 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Money market funds |  |  |  |  |  |  | 174,422 |  |  | 174,422 |  |  | — |  |  | — |  |  | — |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  |  |  |  |  |  | (1,150) |  |  | — |  |  | — |  |  | — |  |  | (1,150) |
Total |  |  |  |  |  |  | $ | 1,059,843 |  |  | $ | 779,298 |  |  | $ | 40,658 |  |  | $ | 241,037 |  |  | $ | (1,150) |
| April 30, 2024
| Fair Value Measurement |  | Balance Sheet Classification
| Cost |  | Unrealized Gains |  | Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities, Current |  | Marketable Securities, Non-current |  | Other Accrued Liabilities
| (in thousands)
Changes in Fair Value Recorded in |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other Comprehensive Loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commercial paper | $ | 16,873 |  |  | $ | 1 |  |  | $ | (19) |  |  | $ | 16,855 |  |  | $ | 3,932 |  |  | $ | 12,923 |  |  | $ | — |  |  | $ | — |
Corporate notes/bonds | 17,322 |  |  | 3 |  |  | (27) |  |  | 17,298 |  |  | — |  |  | 10,050 |  |  | 7,248 |  |  | — |
U.S. Treasury and Agency Securities | 4,355 |  |  | — |  |  | (9) |  |  | 4,346 |  |  | — |  |  | 2,441 |  |  | 1,905 |  |  | — |
Total debt investments | $ | 38,550 |  |  | $ | 4 |  |  | $ | (55) |  |  | $ | 38,499 |  |  | $ | 3,932 |  |  | $ | 25,414 |  |  | $ | 9,153 |  |  | $ | — |
Changes in Fair Value Recorded in |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mutual funds (1) |  |  |  |  |  |  | $ | 219,856 |  |  | $ | — |  |  | $ | 17,328 |  |  | $ | 202,528 |  |  | $ | — |
Total equity investments |  |  |  |  |  |  | $ | 219,856 |  |  | $ | — |  |  | $ | 17,328 |  |  | $ | 202,528 |  |  | $ | — |
Cash |  |  |  |  |  |  | $ | 790,938 |  |  | $ | 790,938 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Money market funds |  |  |  |  |  |  | 146,135 |  |  | 146,135 |  |  | — |  |  | — |  |  | — |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  |  |  |  |  |  | (427) |  |  | — |  |  | — |  |  | — |  |  | (427) |
Total |  |  |  |  |  |  | $ | 1,195,001 |  |  | $ | 941,005 |  |  | $ | 42,742 |  |  | $ | 211,681 |  |  | $ | (427) |
___________________
(1) | These investments are held in trust for settlement of the Company’s vested obligations of $220.3 million and $198.6 million as of January 31, 2025 and April 30, 2024, respectively, under the ECAP (see Note 6 — Deferred Compensation and Retirement Plans). Unvested obligations under the deferred compensation plans totaled $19.9 million and $22.4 million as of January 31, 2025 and April 30, 2024, respectively. During the three and nine months ended January 31, 2025, the fair value of the investments increased; therefore, the Company recognized a gain of $9.1 million and $28.0 million, respectively, which was recorded in other income, net. During the three and nine months ended January 31, 2024, the fair value of the investments increased; therefore, the Company recognized a gain of $23.8 million and $22.8 million, respectively, which was recorded in other income, net.
As of January 31, 2025, available-for-sale marketable securities had remaining maturities ranging from less than 1 month to 24 months. During the three and nine months ended January 31, 2025, there were $7.7 million and $24.5 million in sales/maturities of available-for-sale marketable securities, respectively. During the three and nine months ended January 31, 2024, there were $4.4 million and $30.6 million in sales/maturities of available-for-sale marketable securities, respectively. Investments in marketable securities that are held in trust for settlement of the Company’s vested obligations under the ECAP are equity securities and are based upon the investment selections the employee elects from a pre-determined set of securities in the ECAP and the Company invests in equity securities to mirror these elections. As of January 31, 2025 and April 30, 2024, the Company’s investments in equity securities consisted of mutual funds for which market prices are readily available. Unrealized gains recorded for the period that relate to equity securities still held as of January 31, 2025 and 2024 were $15.1 million and $20.9 million, respectively. Foreign Currency Forward Contracts Not Designated as Hedges The fair value of derivatives not designated as hedge instruments are as follows:
| January 31, 2025 |  | April 30, 2024
| (in thousands)
Derivative assets: |  |  |
Foreign currency forward contracts | $ | 569 |  |  | $ | 979 |
Derivative liabilities: |  |  |
Foreign currency forward contracts | $ | 1,719 |  |  | $ | 1,406 |
As of January 31, 2025, the total notional amounts of the forward contracts purchased and sold were $89.2 million and $37.8 million, respectively. As of April 30, 2024, the total notional amounts of the forward contracts purchased and sold were $82.9 million and $34.0 million, respectively. The Company recognizes forward contracts as a net asset or net liability on the condensed consolidated balance sheets as such contracts are covered by master netting agreements. During the three and nine months ended January 31, 2025, the Company incurred losses of $1.7 million and $2.0 million, respectively, related to forward contracts which are recorded in general and administrative expenses in the accompanying condensed consolidated statements of income. During the three and nine months ended January 31, 2024, the Company incurred gains of $2.4 million and $0.9 million, respectively, related to forward contracts which are recorded in general and administrative expenses in the accompanying condensed consolidated statements of income. These foreign currency losses and gains related to forward contracts offset foreign currency gains and losses that result from transactions denominated in a currency other than the Company’s functional currency. The cash flows related to foreign currency forward contracts are included in cash flows from operating activities.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration